|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19.11.25 - 13:51
|
Ability Biotherapeutics Expands its Scientific Advisory Board with the Appointment of Dr. John Burke and Dr. Alan Korman (Business Wire)
|
|
|
MONTREAL--(BUSINESS WIRE)--#Antibodies--Ability Biotherapeutics, a next-generation biotherapeutics company developing logic-gated antibodies for safer and more effective immunotherapies, announces the appointment of Dr. John Burke and Dr. Alan Korman to its Scientific Advisory Board.
Dr. Alan Korman, Ph.D., Chief Scientific Officer at BlueSphere Bio, is a recognized world pioneer in immunology and cancer immunology with over 30 years of experience in the industry. Prior to joining BlueSphere, he served as the Senior Vice-President of Human Immunology at Vir Biotechnology. Before that, Dr. Korman was the Vice-President of Immuno-Oncology Discovery at Bristol-Myers Squibb (BMS). Earlier, he worked at Medarex in various roles including Vice-President of Discovery Research. While at BMS and Medarex, Dr. Korman led the discovery of the immune checkpoint approaches for cancer immune therapy, including the world's first inhibitor ipilimumab (anti-CTLA-4 Yervoy®), the world's first PD-1 inhibitor nivolumab (an...
|
|
|
18.11.25 - 20:27
|
Bristol Myers Squibb Announces Accepted Amounts and Pricing Terms of its Tender Offers (Business Wire)
|
|
|
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) (“Bristol Myers Squibb”), today announced the accepted amounts and pricing terms of the previously announced tender offers to purchase for cash its outstanding notes listed in the tables below.
The outstanding debt securities listed in (i) the first table below labeled “Pool 1” are referred to collectively as the “Pool 1 Notes” and (ii) the second table below labeled “Pool 2” are referred to collectively as the “Pool 2 Notes.” The Pool 1 Notes and the Pool 2 Notes are referred to collectively as the “Notes” and each series of Notes is referred to as a “series.” We refer to each offer to purchase a series of Notes for cash as an “Offer,” the offers to purchase the Pool 1 Notes collectively as the “Pool 1 Offers,” the offers to purchase the Pool 2 Notes collectively as the “Pool 2 Offers,” and all the offers to purchase Notes are referred to collectively as the “Offers.”
As previously annou...
|
|
|
18.11.25 - 04:36
|
Bristol Myers Squibb Announces Early Participation Results, Amendment and Early Settlement of Tender Offers (Business Wire)
|
|
|
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) (“Bristol Myers Squibb”), today announced the early participation results, as of 5:00 p.m. (New York City time) on November 17, 2025, (the “Early Tender Deadline”) of the previously announced tender offers to purchase for cash its outstanding notes listed in the tables below. Bristol Myers Squibb also announced that it is (i) decreasing the maximum aggregate purchase price of the Pool 1 Notes (as defined below) it will accept for purchase from the previously announced amount of $4,000,000,000 to an amount sufficient (the “Amended Pool 1 Maximum”) to accept for purchase all Pool 1 Notes that were validly tendered and not validly withdrawn prior to the Early Tender Deadline and (ii) increasing the maximum aggregate purchase price of the Pool 2 Notes (as defined below) it will accept for purchase from the previously announced amount of $3,000,000,000 to an amount sufficient (the “Amended Pool 2 Maximum”) to accept for ...
|
|
|
14.11.25 - 17:42
|
Bristol Myers Faces Another Trial Disappointment As Heart Drug Milvexian Fails To Show Efficacy (Benzinga)
|
|
|
Bristol Myers and Johnson & Johnson ended the Librexia ACS trial after an interim review showed low efficacy, while AF and stroke studies continue with data expected in 2026.
Latest Ratings for BMY
DateFirmActionFromTo Mar 2022Wells FargoMaintainsEqual-Weight Dec 2021Goldman SachsInitiates Coverage OnBuy Dec 2021Wells FargoInitiates Coverage OnEqual-Weight
View More Analyst Ratings for BMY
View the Latest Analyst Ratings
read more...
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
